Tjongerschans

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Pancreatic cancer2 trials
• COPD1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting2 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Borstkanker Onderzoek Groep1 trial
• Erasmus Medical Center1 trial
• Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)1 trial
• University Medical Center Groningen1 trial

Running trials

• Active, not recruiting

  Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

  NCT04927780· Phase 3· Erasmus Medical Center· Source

• Active, not recruiting

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· Phase 3· Borstkanker Onderzoek Groep· Source

Closed trials

• Completed

  THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)

  2024-516260-29-00· Phase 3· Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)· Source

• Terminated

  Influence of PESF on Oxygen Saturation, Quality of Life and Exercise Capacity in COPD

  NCT03797794· University Medical Center Groningen· Source